ASCENDO BIOTECHNOLOGY
Ascendo Biotechnology therapeutic strategies focus on the interplay between the natural innate and adaptive immune pathways to reinvigorate the immunity of the tumor microenvironment for anti tumor response.
ASCENDO BIOTECHNOLOGY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-01-01
Address:
Neihu, T'ai-wan, Taiwan
Country:
Taiwan
Website Url:
http://www.ascendobiotech.com
Total Employee:
11+
Status:
Active
Contact:
+886 2 7728 8922
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Maps Cloudflare Hosting
Similar Organizations
Aquros Bio
Aquros Bio develops bladder-directed therapies for unmet acute and chronic urological conditions.
Bostal Drug Delivery
Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems.
Immunitor
Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.
ImmunoHiTech
ImmunoHiTech develops immunotherapy products that provides reduction of metastatic spread in cancer patients.
NLT SPINE
NLT SPINE develops minimally invasive spinal surgery products for the treatment of degenerative spinal conditions.
Rebiotic Rx
Rebiotic Rx is develops novel liposomal antibiotics for antibiotic-resistant bacterial infections.
Swiss Rockets
Swiss Rockets focuses on the development of new treatment therapies and clinical drugs for cancer patients.
Current Employees Featured
Official Site Inspections
http://www.ascendobiotech.com Semrush global rank: 8.46 M Semrush visits lastest month: 531
- Host name: 172.67.222.244
- IP address: 172.67.222.244
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ascendo Biotechnology"
Novel Immunotherapeutics & Innate Immune Research …
ASD141 works by blocking TLT-1, a key regulatory protein that induces the immune suppressive environment in the tumor. Blocking TLT-1 binding to receptor CD11b reinvigorates the innate cells that coordinate an immune …See details»
Ascendo Biotechnology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +886 2 7728 8922 Ascendo Biotechnology therapeutic strategies focus on the interplay between the natural innate and …See details»
Pioneering Cancer Immunotherapies & Vaccines | Ascendo …
Introduction. Ascendo Biotechnology is a fast-growing biotechnology company based in Taiwan that is pioneering novel approaches to developing cancer immunotherapies and functional …See details»
Ascendo Biotechnology, Inc. - Drug pipelines, Patents, Clinical …
Www.ascendobiotech.com. Startups | Private Company | 2019 | Taiwan Province, China | 10-50 | www.ascendobiotech.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Ascendo Biotechnology, Inc. | The Org
We seek to break through the limitations of current immunotherapies and achieve meaningful responses in patients. Our novel approach optimises the natural innate and adaptive immune …See details»
Ascendo Biotechnology, Inc. | LinkedIn
Https://www.ascendobiotech.com External link for Ascendo Biotechnology, Inc. Industry Biotechnology Research Company size 11-50 employees ...See details»
Team - ASCENDO Biotechnology
Dr. Jason HUANG (MD/JD) CEO / Founder CMO. 20+ years of experience in pharma industry; Expert of Janssen Pharmaceutical (a company of J&J) Ex-Regional Therapeutic Area (Immunology, Infectious disease and Vaccine) Ex …See details»
Ascendo Biotechnology, Inc. Overview | SignalHire Company Profile
We seek to break through the limitations of current immunotherapies and achieve meaningful responses in patients. Our novel approach optimises the natural innate and adaptive immune …See details»
Ascendo Biotechnology, Inc. - VentureRadar
"Ascendo Biotechnology is dedicated to optimizing and reinvigorating the natural, innate immune pathway to deliver comprehensive anti-tumor responses and reduce infectious disease harm.See details»
Ascendo Biotechnology, Inc. - Drug pipelines, Patents, Clinical …
Last update 22 Feb 2024. Ascendo Biotechnology, Inc. Startups |See details»
Ascendo Biotechnology - Products, Competitors, Financials, …
Ascendobiotech.com. Overview & Products; People; Founded Year 2019. About Ascendo Biotechnology. Ascendo Biotechnology focuses on developing cancer immunotherapies and …See details»
Ascendo Biotechnology - Contacts, Employees, Board Members, …
Ascendo Biotechnology develops cancer immunotherapies and functional cures for chronic viral infections.See details»
Ascendo Biotechnology, Inc. (Ascendo Biotechnology, Inc.) - 药物 …
Studies have shown that elevated plasma levels of platelet-derived soluble TREM-like transcript-1 (sTLT-1) are associated with an unfavorable outcome in patients with septic shock.See details»
AscendBio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for AscendBio. Use the PitchBook Platform to explore the full profile.See details»
Ascendo developing solution to rapid virus mutations
Jun 21, 2021 Doctors and scientists have been racking their brains for a solution to the constantly mutating virus. Using quantum mechanics calculations, Ascendo can produce …See details»
Science - ASCENDO Biotechnology
Partner of choice for novel immunotherapeutics. Ascendo Biotechnology is a strategic partner of choice for novel immunotherapies which exploit the interplay between the innate and adaptive …See details»
Versatile Vaccine Delivery System - ASCENDO Biotechnology
What is NanoCherub ®?. NanoCherub ® is a nanocomplex vaccine delivery system with an adjuvant-like effect that utilizes dense positive charges to produce a sustained, non-polarized …See details»
ASD141 在 转移性实体瘤-临床试验注册中心-ICH GCP
Jan 18, 2024 纳入标准： 受试者已通过书面知情同意书自愿同意参与。 签署知情同意书之日年满 18 周岁的男性或女性。 患有经组织学或细胞学证实的转移性实体瘤，目前尚无可预期带来临床 …See details»
Pipeline | Targeting Solid Tumors & Chronic Viral Infection
Pipeline. Our pipeline is driven by our revolutionary research into immune response. Each product builds on our unique understanding of innate immunity and how this natural control can be …See details»
News - ASCENDO Biotechnology
Oct 14, 2021 Ascendo highlights the limitless potential of the adaptive immune pathway for future cancer immunotherapies at the 2022 International BIO conventionSee details»